Physician profile
Reginald B Griffith
NPI 1457309759
$1,975.16
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $355 · 2021: $531 · 2022: $459 · 2023: $219 · 2024: $47.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $464.95 | 2019-2022 | |
| Pacira Therapeutics, INC. | $426.43 | 2019-2021 | |
| Depuy Synthes Sales INC. | $314.09 | 2019-2024 | Monovisc |
| Smith+Nephew, INC. | $163.39 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $141.78 | 2019-2023 | Euflexxa |
| Biorez, INC. | $120.24 | 2022 | |
| Sanofi-Aventis U.S. LLC | $76.87 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $68.65 | 2020-2024 | Iovera, Zilretta, Exparel |
| Stryker Corporation | $61.59 | 2019-2020 | |
| Boston Scientific Corporation | $53.09 | 2023 | |
| Ethicon US, LLC | $26.72 | 2021 | |
| Convatec INC. | $24.25 | 2022 | |
| Cook Medical LLC | $16.23 | 2023 | Zenith Spiral-Z |
| Bioventus LLC | $14.92 | 2024 | Durolane |
| Fidia Pharma USA INC. | $1.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reginald Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.